Xiubao Ren - Tianjin Medical University Cancer Institude & Hospital

基本信息

Career Trajectory

Bio

在肿瘤免疫治疗的临床与基础研究方面卓有建树，特别是将常规化疗与现代生物治疗技术(如肿瘤疫苗治疗、CIK细胞治疗、分子靶向药物治疗、异基因造血干细胞移植免疫治疗等)有机地结合在一起，逐步形成了“化疗-祛邪、免疫-固本”的肿瘤个体化生物治疗新模式。积极探索和推动免疫治疗新技术、新项目的开展与应用，在肺癌、肾癌、恶性黑色素瘤、卵巢癌等实体瘤的治疗方面开展了大量的临床研究工作，积累了丰富的临床经验.

Research Interests

Papers共 676 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Expert Consensus on the Diagnosis and Treatment of Non-Small Cell Lung Cancer with MET Alteration

Huijing Feng,Yang Xia,Wenxian Wang,Chunwei Xu,Qian Wang,Zhengbo Song,Ziming Li,Jinpu Yu,Wenzhao Zhong,Zhijie Wang,Yongchang Zhang, Jingjing Liu,Shirong Zhang,Xiuyu Cai,Anwen Liu,Wen Li,Ping Zhan,Hongbing Liu, Tangfeng Lyu,Liyun Miao,Lingfeng Min,Gen Lin,Long Huang,Jingping Yuan,Zhansheng Jiang, Xingxiang Pu,Chuangzhou Rao, Dongqing Lyu,Zongyang Yu,Xiaoyan Li,Chuanhao Tang,Chengzhi Zhou,Qi Mei,Hui Guo,Qian Chu,Rui Meng,Xuewen Liu,Jingxun Wu,Jin Zhou,Zhengfei Zhu,Weiwei Pan,Fei Pang, Meizhen Hu,Kai Wang, Fan Wu, Bingwei Xu, Ling Xu,Liping Wang,Youcai Zhu, Jisheng Li,Yanru Xie,Xinqing Lin,Jing Cai,Lin Wang,Yingying Du,Wang Yao,Xuefei Shi,Xiaomin Niu,Dongmei Yuan,Yanwen Yao,Jing Kang,Jiatao Zhang,Chao Zhang,Wenbin Gao,Jianhui Huang,Yinbin Zhang,Pingli Sun,Hong Wang,Mingxiang Ye,Dong Wang, Zhaofeng Wang, Yue Hao,Zheng Wang,Bing Wan, Donglai Lyu,Xiaodong Jiao,Lin Shi, Gang Lan, Shengjie Yang,Yanhong Shang,Yina Wang, Bihui Li,Gang Jin, Kang Zheng,Jun Ma,Wenfeng Li, Zhang,Zhongwu Li,Yuan Li,Zhefeng Liu,Xuelei Ma,Nong Yang,Lin Wu,Qiming Wang,Guansong Wang, Zhuan Hong,Jiandong Wang, Meiyu Fang,Yong Fang,Xixu Zhu,Yi Shen,Ke Wang,Xiubao Ren,Yiping Zhang,Shenglin Ma,Junping Zhang,Yong Song,Wenfeng Fang,Yuanzhi Lu

Cancer biology & medicineno. 3 (2025)

Cited0Views0WOSBibtex

Genetic Biomarker Study of Sunvozertinib for Clinical Prognosis and Prediction in NSCLC with EGFR Exon 20 Insertion Mutation

Yan Xu,James Chih-Hsin Yang, Yanqiu Zhao, Ludovic Doucet,Jianying Zhou,Yongsheng Wang,David Planchard,Yun Fan,Bo Jin,Zhigang Han, Laurent Greillier,Julien Mazieres,Meili Sun,Ying Hu, Xia Song,Cuimin Ding,Lin Wu,Kejing Tang,Li Liang,Yu Yao,Ying Cheng,Yong He, Bruna Pellini Ferreira,François Ghiringhelli,Enriqueta Felip,Joaquim Bosch-Barrera,Anwen Liu,Yan Yu,Xiaorong Dong,Junzhen Gao, D Ross Camidge,Weiqi Nian,Chengzhi Zhou,Runxiang Yang, Thomas John,Bo Gao,Lyudmila Bazhenova,Misako Nagasaka, Jianghong Wang,Xiubao Ren,Fei Xu,Wen Li,Dahai Zhao, Huijie Wang,Si Sun, Jian'an Huang, Xuehua Zhu, Li Zheng,Pasi A Jänne,Mengzhao Wang

Cell reports Medicineno. 5 (2025): 102121-102121

Cited0Views0WOSBibtex

CK2B Induces CD8+ T-Cell Exhaustion Through HDAC8-Mediated Epigenetic Reprogramming to Limit the Efficacy of Anti-PD-1 Therapy in Non-Small-Cell Lung Cancer

Shaochuan Liu, Shiya Ma, Gen Liu, Lingjie Hou,Yong Guan,Liang Liu,Yuan Meng,Wenwen Yu,Ting Liu,Li Zhou,Zhiyong Yuan, Shuju Pang, Siyuan Zhang, Junyi Li,Xiubao Ren,Qian Sun

Advanced science (Weinheim, Baden-Wurttemberg, Germany)no. 16 (2025): e2411053-e2411053

Cited0Views0WOSBibtex

Risk Role of Genetically Predicted Serum Iron Status on Thyroid Cancer

Xiao Tian, Ting Liu,Xiubao Ren

Nutrition and cancerpp.1-13, (2025)

Cited0Views0WOSBibtex

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Xiangqin Zhao, Xinbo Gao,Wenwen Yu, Yi Lu, Xuesong Li, Lu Tan,Xiubao Ren,Yifei Wang, Weijie Song,Jihui Hao,Ying Ma

Journal of visualized experiments JoVE (2025)

Cited0Views0WOSBibtex

Liver Protection of CACA Technical Guidelines for Holistic Integrative Management of Cancer

Ningning Zhang,Lungen Lu,Baoshan Cao,Yanjing Gao,Feng Han,Liangping Li, Qijiong Li,Shuchen Li, Xiaowu Li, Jingfeng Liu,Yefu Liu, Yingqian Lv,Yongzhan Nie,Xizhong Shen,Dongde Wu,Qiang Wu,Jun Xu, Liping Yao,Ning Zhang,Yuzheng Zhuge,Xiubao Ren, De’an Tian,Guohong Han,Wei Lu

Holistic Integrative Oncologyno. 1 (2025): 1-33

Cited0Views0Bibtex

Rapid and High-Throughput Screening of Proteolysis Targeting Chimeras Using a Dual-Reporter System Expressing Fluorescence Protein and Luciferase

Shuai Meng,Yuan Meng,Xuena Yang,Wenwen Yu,Bole Li,Tianjun Liu, Jie Zhang,Xiubao Ren, Lin Zhang

BMC Biologyno. 1 (2025): 1-17

Cited0Views0WOSBibtex

Efficacy and Safety of the Bevacizumab Biosimilar SIBP04 Compared with Bevacizumab (avastin®) As First-Line Treatment for Locally Advanced or Metastatic Non-Squamous Non-Small-cell Lung Cancer: A Randomized, Double-Blind, Phase 3 Trial

Yuankai Shi,Minghong Bi, Qingshan Li,Guolei Wang,Jianhua Chen, Mingjun Li,Jianhua Shi, Jiazhuan Mei, Yinghua Ji, Qingdi Xia, Yuanqing Feng, Shufeng Xu,Tongmei Zhang, Xiaohui Gao, Shubin Tang,Jie Weng,Zhuo Cao, Hongbo Wu,Xiubao Ren, Hua Xie

Cancer Pathogenesis and Therapy (2025)

Cited0Views0Bibtex

STING Licensing of Type I Dendritic Cells Potentiates Antitumor Immunity

Jian Wang,Suxin Li, Maggie Wang,Xu Wang, Shuqing Chen,Zhichen Sun,Xiubao Ren,Gang Huang,Baran D. Sumer,Nan Yan,Yang-Xin Fu,Jinming Gao

CANCER RESEARCH（2024）

Cited10Views0WOSSCIENCEBibtex

1789P Second OS Interim Analysis from BEAT-SC: A Randomized Phase III Study of Bevacizumab (bev) or Placebo in Combination with Atezolizumab and Platinum-Based Chemotherapy in Patients with Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

B. Han,Y. Ohe, M. Nishio, S. Watanabe,X. Ren, S. Murakami, N. Yang,I. Okamoto, G. Li,N. Katakami, X. Liu, N. Hamaguchi, Y. Nakagawa, M. Hayashi,T. Nanki, C. Qian, N. Yamamoto

Annals of Oncology (2024): S1063-S1064

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Xiubao Ren(任秀宝)

Professor

Papers共 676 篇Author StatisticsCo-AuthorSimilar Experts